JP2021051056A - インプラント周囲感染の診断方法または病態判定方法 - Google Patents
インプラント周囲感染の診断方法または病態判定方法 Download PDFInfo
- Publication number
- JP2021051056A JP2021051056A JP2019186346A JP2019186346A JP2021051056A JP 2021051056 A JP2021051056 A JP 2021051056A JP 2019186346 A JP2019186346 A JP 2019186346A JP 2019186346 A JP2019186346 A JP 2019186346A JP 2021051056 A JP2021051056 A JP 2021051056A
- Authority
- JP
- Japan
- Prior art keywords
- peri
- myeloperoxidase
- diagnosing
- implantitis
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 11
- 208000006389 Peri-Implantitis Diseases 0.000 title abstract 3
- 230000007170 pathology Effects 0.000 title abstract 3
- 102000003896 Myeloperoxidases Human genes 0.000 claims abstract description 23
- 108090000235 Myeloperoxidases Proteins 0.000 claims abstract description 23
- 210000001124 body fluid Anatomy 0.000 claims abstract description 7
- 239000010839 body fluid Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims abstract description 7
- 238000003745 diagnosis Methods 0.000 claims abstract description 6
- 206010064687 Device related infection Diseases 0.000 claims description 14
- 230000001575 pathological effect Effects 0.000 claims description 6
- 238000002965 ELISA Methods 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 230000004520 agglutination Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 238000003317 immunochromatography Methods 0.000 claims 1
- 238000010324 immunological assay Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 2
- 206010053555 Arthritis bacterial Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 102000018568 alpha-Defensin Human genes 0.000 description 1
- 108050007802 alpha-defensin Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 108091006374 cAMP receptor proteins Proteins 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 108010000849 leukocyte esterase Proteins 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
- 体液中のミエロペルオキシダーゼを測定対象にすることを特徴とするインプラント周囲感染の診断方法または病態判定方法。
- 酵素免疫法やラテックス凝集反応、免疫クロマトグラフ法などの免疫学的測定法を用いたミエロペルオキシダーゼ測定および酵素反応を用いたミエロペルオキシダーゼ活性測定を特徴とする請求項1記載のインプラント周囲感染の診断または病態判定に用いるキット。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019186346A JP2021051056A (ja) | 2019-09-21 | 2019-09-21 | インプラント周囲感染の診断方法または病態判定方法 |
PCT/JP2020/039199 WO2021054485A1 (ja) | 2019-09-21 | 2020-09-21 | インプラント周囲感染の診断方法または病態判定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019186346A JP2021051056A (ja) | 2019-09-21 | 2019-09-21 | インプラント周囲感染の診断方法または病態判定方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021051056A true JP2021051056A (ja) | 2021-04-01 |
Family
ID=74883562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019186346A Pending JP2021051056A (ja) | 2019-09-21 | 2019-09-21 | インプラント周囲感染の診断方法または病態判定方法 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2021051056A (ja) |
WO (1) | WO2021054485A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2022328390A1 (en) | 2021-08-10 | 2024-03-21 | Adimab, Llc | Anti-gdf15 antibodies, compositions and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10139405B2 (en) * | 2012-01-24 | 2018-11-27 | Cd Diagnostics, Inc. | System for detecting infection in synovial fluid |
US20170045532A1 (en) * | 2014-04-22 | 2017-02-16 | Javad Parvizi | Materials and methods for diagnosis of peri-implant bone and joint infections using prophenoloxidase pathway |
WO2017023929A1 (en) * | 2015-08-04 | 2017-02-09 | Cd Diagnostics, Inc. | Methods for detecting adverse local tissue reaction (altr) necrosis |
-
2019
- 2019-09-21 JP JP2019186346A patent/JP2021051056A/ja active Pending
-
2020
- 2020-09-21 WO PCT/JP2020/039199 patent/WO2021054485A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021054485A1 (ja) | 2021-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105579852A (zh) | 用于诊断肠易激惹综合征的途径特异性标志物 | |
JP5663723B2 (ja) | 関節リウマチの診断のための方法およびキット | |
WO2021054485A1 (ja) | インプラント周囲感染の診断方法または病態判定方法 | |
JP6613241B2 (ja) | Mmp−8活性化物質及び同物質の判定並びに使用 | |
Yenigun | The efficacy of tonsillectomy in chronic tonsillitis patients as demonstrated by the neutrophil-to-lymphocyte ratio | |
Amalesh et al. | CRP in acute appendicitis—is it a necessary investigation? | |
CN102822675A (zh) | 降钙素原用于在具有非特异性不适的患者中诊断细菌感染和指导抗生素治疗 | |
WO2019141525A1 (en) | Periodontal disease diagnostic methods, uses and kits | |
JP2015528912A (ja) | 強皮症の診断方法 | |
JP7486316B2 (ja) | 唾液のil-1ベータ及びmmp-9に基づく軽度の又は進行した歯周炎の診断 | |
WO2019197543A3 (en) | Periodontitis diagnostic methods, uses and kits | |
ES2484720T3 (es) | Marcadores moleculares para infecciones de las vías urinarias | |
JP2024020276A (ja) | 歯肉炎の診断方法、使用、キット | |
EP3631458A1 (en) | Diagnostics of periodontitis based on salivary hgf and mmp-8 | |
Kraemer et al. | Automated Fecal Biomarker Profiling-a Convenient Procedure to Support Diagnosis for Patients with Inflammatory Bowel Diseases. | |
KR20110049781A (ko) | 신경변성 질환에 대한 진단적/예후적 지표로서 글루타미닐 사이클라제 | |
CN105008549A (zh) | 测量骨损失率的方法 | |
KR20200080183A (ko) | 치주질환 진단 방법, 이를 위한 조성물 및 키트 | |
US20140273032A1 (en) | Compositions and methods for diagnosis of schizophrenia | |
JP2018506720A (ja) | 抗ccpおよび抗pik3cdを測定することによる関節リウマの査定方法 | |
RU2263918C2 (ru) | Способ диагностики острого пиелонефрита | |
WO2017151794A1 (en) | Methods utilizing d-dimer for diagnosis of periprosthetic joint infection | |
US20210302420A1 (en) | Diagnostic method for systemic lupus erythematosus using smyd3 autoantibody | |
ES2698157B2 (es) | Cito-periopredictor | |
Iazajii | Virulence factors of Candida albicans strains |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221001 |
|
A917 | Reason for reinstatement of right to file examination request |
Free format text: JAPANESE INTERMEDIATE CODE: A917 Effective date: 20221128 |
|
A59 | Written plea |
Free format text: JAPANESE INTERMEDIATE CODE: A59 Effective date: 20230527 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231024 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231224 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231231 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240510 |